APA (7th ed.) Citation

K, K., Y, K., K, N., K, S., T, I., T, N., . . . T, T. (2026). Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma. In vivo (Athens, Greece), 40(3), 1796. https://doi.org/10.21873/invivo.14332

Chicago Style (17th ed.) Citation

K, Kikuchi, et al. "Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma." In Vivo (Athens, Greece) 40, no. 3 (2026): 1796. https://doi.org/10.21873/invivo.14332.

MLA (9th ed.) Citation

K, Kikuchi, et al. "Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma." In Vivo (Athens, Greece), vol. 40, no. 3, 2026, p. 1796, https://doi.org/10.21873/invivo.14332.